Compare PRSU & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRSU | PSNL |
|---|---|---|
| Founded | 1926 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 960.2M | 872.1M |
| IPO Year | N/A | 2019 |
| Metric | PRSU | PSNL |
|---|---|---|
| Price | $34.35 | $8.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $31.67 | $10.71 |
| AVG Volume (30 Days) | 228.0K | ★ 1.5M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 902.95 | N/A |
| EPS | ★ 10.75 | N/A |
| Revenue | ★ $441,143,000.00 | $69,103,000.00 |
| Revenue This Year | $26.24 | N/A |
| Revenue Next Year | $8.01 | $20.33 |
| P/E Ratio | $3.38 | ★ N/A |
| Revenue Growth | ★ 4.63 | N/A |
| 52 Week Low | $26.66 | $2.83 |
| 52 Week High | $43.83 | $11.40 |
| Indicator | PRSU | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 45.67 |
| Support Level | $35.24 | $7.68 |
| Resistance Level | $37.85 | $9.10 |
| Average True Range (ATR) | 1.01 | 0.57 |
| MACD | -0.13 | -0.12 |
| Stochastic Oscillator | 17.69 | 26.07 |
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.